Irinotecan-Induced Dysarthria

Publisher： Karger

E-ISSN： 1662-6575|5|1|47-51

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.5, Iss.1, 2012-01, pp. : 47-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Irinotecan‐induced muscular contractions

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention of Irinotecan-Induced Diarrhea by Oral Sodium Bicarbonate and Influence on Pharmacokinetics

By  

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 327-337

Karger

Access to resources Recommend Favorite

Involvement of matrix metalloproteinases (MMP‐3 and MMP‐9) in the pathogenesis of irinotecan‐induced oral mucositis

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 6, 2015-07 ,pp. : 459-467

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐18 as a target for modulation of irinotecan‐induced intestinal toxicity: a step towards a better therapeutic index?: Commentary on Lima‐Junior et al., Br J Pharmacol 171: 2335–2350

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 19, 2015-10 ,pp. : 4779-4781

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimating the Intelligibility of Speakers with Dysarthria

By  

Folia Phoniatrica et Logopaedica, Vol. 58, Iss. 3, 2006-04 ,pp. : 217-228

Karger

Access to resources Recommend Favorite